C6orf183 Activators
Chemical activators of C6orf183 utilize various cellular mechanisms to modulate its activity through phosphorylation. Forskolin, by elevating intracellular cAMP levels, can activate protein kinase A, which in turn can phosphorylate C6orf183. This phosphorylation state often serves as a switch to turn on the functional activity of proteins. Similarly, ionomycin can raise intracellular calcium levels, leading to the activation of calcium-dependent kinases such as calmodulin-dependent kinase. This kinase, in response to the increased calcium levels, can target proteins like C6orf183 for phosphorylation, altering its activity within the cell. Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C, which is known for its broad range of protein targets for phosphorylation, potentially including C6orf183 as well. On the other side of phosphorylation, calyculin A and okadaic acid act by inhibiting protein phosphatases, enzymes responsible for removing phosphate groups. This inhibition can result in a sustained phosphorylation state for proteins like C6orf183, thereby maintaining its activity.
Anisomycin activates stress-activated protein kinases such as JNK, which can phosphorylate a wide array of substrates, possibly including C6orf183. Thapsigargin, by inhibiting SERCA, leads to increased cytosolic calcium levels, which can activate kinases that target proteins such as C6orf183. Growth factors like EGF initiate a phosphorylation cascade via the MAPK/ERK pathway, which can also target C6orf183. Likewise, TNF-α activates kinases through its receptor signaling pathways, which can influence the phosphorylation state and activity of C6orf183. Hydrogen peroxide, a signaling molecule, can activate MAP kinases, potentially affecting the phosphorylation status of C6orf183. Finally, bisindolylmaleimide I, although typically a PKC inhibitor, can under certain circumstances activate kinases that may phosphorylate C6orf183, and 6-benzylaminopurine, a cytokinin, can alter cellular signaling and phosphorylation patterns, affecting the activity of kinases that can act on C6orf183. Each of these chemicals, through their respective pathways, can contribute to the regulation of C6orf183 activity within the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin acts as a calcium ionophore, raising intracellular calcium levels. This increase can activate calcium-dependent kinases such as CaMK (calmodulin-dependent kinase), which could phosphorylate and activate C6orf183, provided that C6orf183 is a substrate for CaMK or is regulated by CaMK-dependent phosphorylation of other interacting proteins. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which could lead to the phosphorylation and activation of C6orf183 if it is a substrate of PKC or if PKC phosphorylation alters the activity of other proteins that directly regulate C6orf183. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A inhibits protein phosphatases 1 and 2A, preventing dephosphorylation of proteins. This inhibition could result in a sustained phosphorylation state of C6orf183, provided C6orf183's activity is regulated by phosphorylation and dephosphorylation cycles. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid is a potent inhibitor of protein phosphatases, particularly PP1 and PP2A. By inhibiting dephosphorylation, Okadaic Acid may lead to an increased phosphorylation state of C6orf183, thereby maintaining its activation, depending on whether C6orf183 is regulated by phosphorylation. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates stress-activated protein kinases such as JNK. Activation of JNK could lead to phosphorylation and activation of C6orf183 if JNK directly phosphorylates C6orf183 or modifies the activity of proteins that regulate C6orf183. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to increased cytosolic calcium levels, which can activate kinases that phosphorylate and activate C6orf183 if those kinases target C6orf183 or proteins that control C6orf183 activity. | ||||||
Hydrogen Peroxide | 7722-84-1 | sc-203336 sc-203336A sc-203336B | 100 ml 500 ml 3.8 L | $31.00 $61.00 $95.00 | 28 | |
H2O2 induces oxidative stress, which can activate MAP kinases that phosphorylate and activate C6orf183, provided that C6orf183 is a substrate for MAP kinases or is regulated by proteins whose activity is modulated by oxidative stress signaling. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I, while known as a PKC inhibitor, can also activate other kinases under certain conditions, potentially affecting the phosphorylation status and activation of C6orf183, assuming C6orf183 is regulated by such kinases. | ||||||
6-Benzylaminopurine | 1214-39-7 | sc-202428 sc-202428A | 1 g 5 g | $20.00 $52.00 | ||
6-Benzylaminopurine, a cytokinin, can alter cellular signaling and phosphorylation patterns, potentially leading to the activation of kinases that phosphorylate and activate C6orf183, if C6orf183 is a substrate for these kinases or is part of a pathway regulated by cytokinin signaling. | ||||||